Epizyme, Inc. (EPZM) Social Stream



Epizyme, Inc. (EPZM): $1.47

0.02 (-1.34%)

POWR Rating

Component Grades

Momentum

F

Stability

F

Sentiment

Quality

C

Add EPZM to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#93 of 402

in industry

EPIZYME INC (EPZM) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering EPZM.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 5 $15 $5 $10 $1.52 557.89%
2022-01-10 4 $15 $3 $10.5 $1.52 590.79%
2022-01-28 4 $15 $2 $10.25 $1.52 574.34%
2022-03-01 4 $15 $2 $9.25 $1.52 508.55%
2022-05-11 4 $10 $2 $7.25 $1.52 376.97%
2022-05-12 4 $10 $0.6 $6.4 $1.52 321.05%
2022-06-03 4 $8 $0.6 $5.4 $1.52 255.26%
2022-06-28 4 $6 $0.6 $2.387 $1.52 57.04%

The Trend in the Analyst Price Target


EPZM's average price target has moved down $4.86 over the prior 48 days.

Over the past 33 weeks, EPZM's average upside potential has been 559.6%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-10 4 15 5.0 11.00 4.830 127.74%
2021-11-10 5 15 5.0 10.00 4.830 107.04%
2021-12-22 4 15 3.0 10.50 3.020 247.68%
2022-01-21 4 15 2.0 10.25 2.070 395.17%
2022-05-11 4 10 0.6 6.40 0.468 1267.52%

EPZM Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.5 1 0 3 0 0 4

The Trend in the Broker Recommendations


Over the past 26 weeks, EPZM's average broker recommendation rating worsened by 0.5.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, EPIZYME INC's variance in analysts' estimates is lower than -835.33% of them.
  • EPIZYME INC's average analyst price target is higher than 68.05% of all US stocks.
  • In terms of how EPIZYME INC fares relative to stocks in the mid market cap category, note that its upside potential (average analyst target price relative to current price) is greater than 914.13% of that group.
  • EPIZYME INC's number of analysts covering the stock is higher than 165.59% of stocks in the mid market cap category.

In the Pharmaceutical Products industry, ENTA, EBS, and DVAX are the three stocks most similar to EPIZYME INC regarding the price target and analyst recommendation information presented here.

Is EPZM a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!